Sign Up to like & get
recommendations!
0
Published in 2020 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms21238970
Abstract: Imatinib, one of the most used therapeutic agents to treat leukemia, is an inhibitor that specifically blocks the activity of tyrosine kinases. The molecule of imatinib is flexible and contains several functional groups able to…
read more here.
Keywords:
containing compounds;
crystal structures;
structures imatinib;
intermolecular interactions ... See more keywords